PROCEPT BioRobotics Corp (PRCT): Kapitalisasi marang pendapatan
PROCEPT BioRobotics is implementing AquaBeam automated platforms for precision tissue removal, expanding its reach through educational alliances with urologists. P/S fluctuations reflect the market valuation of revenue, with the metric holding at 3.80. High barriers to entry are driven by patent protection and significant clinic re-equipment costs, which block customer migration to other providers.
Rincian analitis perusahaan PROCEPT BioRobotics Inc (PRCT)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal PROCEPT BioRobotics|PRCT - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Procept|PRCT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku PROCEPT BioRobotics Inc|PRCT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan PROCEPT BioRobotics|Rasio jangkoan perantara procept-biorobotics.com
- data bathi lan kelipatan valuasi:
PRCT - Bathi resik|Bathi resik sing dikarepake PROCEPT BioRobotics|PRCT - Rasio rega marang bathi|Pangali forward rega marang bathi PROCEPT BioRobotics Corp|PRCT - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA PROCEPT BioRobotics Inc|PRCT - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan PROCEPT BioRobotics|PRCT - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan procept-biorobotics.com|PRCT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep PROCEPT BioRobotics
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:PRCT procept-biorobotics.com
Due to inelastic demand for Aquablation technology and the ability to dictate pricing to clinics, PROCEPT BioRobotics (PRCT) possesses significant pricing power, as reflected in its P/S ratio. This multiple relates market capitalization to annual sales volume, determining the cost of each dollar of revenue. An analysis of the industry-average P/S for the company allows for an assessment of whether the premium for product uniqueness is justified or if the asset is overvalued.
Pesaing PROCEPT BioRobotics
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|CNMD: Multiplikator P/S|Rasio kapitalisasi marang pendapatan PLSE|INMD (InMode) - Multiplikator P/S|Picard Medical Corp (PMI) - Koefisien rega marang pendapatan|Multiplikator P/S SRDX|Kapitalisasi marang pendapatan Eversense SENS|Multiplikator P/S NPCE (NeuroPace, Inc.)|Multiplikator P/S Tactile Systems Technology, Inc. TCMD|SNWV - Rasio rega marang pendapatan|OM: Rasio rega marang pendapatan|ELMD (smartvest.com) - Kapitalisasi marang pendapatan|LENSAR Inc - Rasio kapitalisasi pasar marang pendapatan|RCEL (AVITA Medical, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|Profusa Inc (PFSA) - Rasio rega marang pendapatan|Rasio rega marang dodolan SSKN (STRATA Skin Sciences, Inc.)|Rasio rega marang pendapatan GlucoTrack, Inc.|NAOV: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Venus Concept Corp (VERO)|NUWE - Rega marang dodolan|Multiplikator P/S AEMD (Aethlon Medical)|ASXC - Kapitalisasi marang pendapatan|Avinger - Multiplikator P/S|Rega marang dodolan BioSig|Cutera, Inc (CUTR) - Rasio rega marang pendapatan|Rasio rega marang dodolan KNW (Know Labs Corporation)|Kapitalisasi marang pendapatan NARI|NVRO (nevro.com) - Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Rasio kapitalisasi pasar marang pendapatan
